SCHEMBL22026382

SCHEMBL22026382

CC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ IGF2R P11717 2/20 0.48
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ AMY1A P0DUB6 1/20 0.44
▸ LGALS8 O00214 1/20 0.44
▸ LGALS3 P17931 1/20 0.44
▸ LGALS4 P56470 1/20 0.44
▸ SELE P16581 1/20 0.43
▸ FGF1 P05230 1/20 0.43
▸ FGF2 P09038 1/20 0.43
▸ VEGFA P15692 1/20 0.43
▸ HPSE Q9Y251 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ STAT3 P40763 4/20 0.42
▸ MAPT P10636 1/20 0.42
▸ AMY2A P04746 1/20 0.41
▸ PTPN1 P18031 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19480148 0.92 IGF2R (0.46) IGF2RMEN1KMT2AAMY1ALGALS8
SCHEMBL19480247 0.92 IGF2R (0.46) IGF2RMEN1KMT2AAMY1ALGALS8
SCHEMBL16587627 0.88 AMY1A (0.47) IGF2RAMY1ASELESTAT3PTPN1
SCHEMBL16869952 0.88 AMY1A (0.47) IGF2RAMY1ASELESTAT3PTPN1
SCHEMBL19480243 0.87 IGF2R (0.42) IGF2RMEN1KMT2AAMY1ALGALS3
SCHEMBL24239941 0.87 FGF2 (0.40) IGF2RAMY1AFGF2HPSEMAPT
SCHEMBL22844793 0.87 FGF2 (0.40) IGF2RAMY1AFGF2HPSEMAPT
SCHEMBL26032277 0.87 AMY1A (0.54) IGF2RMEN1KMT2AAMY1ALGALS8
SCHEMBL16587625 0.87 SELE (0.48) IGF2RMEN1KMT2AAMY1ASELE
SCHEMBL27279098 0.86 AMY1A (0.51) IGF2RMEN1KMT2AAMY1ALGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200163983-A1 SAPONIN COMPOUND TARGETING PD-1 AND APPLICATION THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2020-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200163983-A1 SAPONIN COMPOUND TARGETING PD-1 AND APPLICATION THEREOF PDCD1, CD274, PDCD1LG2 IGF2R 1923/4885MEN1 2041/4885KMT2A 3424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback